Patents by Inventor Teri Suzuki

Teri Suzuki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acylated indanyl amines and their use as pharmaceuticals
    Patent number: 8163751
    Abstract: The present invention relates to acylated indanyl amines according to the general formula (I) wherein R1-R4 have the meanings given in the description, A is CH2, CHOH or CH—(C1-C3-alkyl), B is CH2 or CH—(C1-C3-alkyl), and R5 is an aryl or heteroaryl group, possibly substituted by the substituents listed in the description.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: April 24, 2012
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Hartmut Strobel, Paulus Wohlfart, Alena Safarova, Armin Walser, Teri Suzuki, Karl Schönafinger, Ramalinga M. Dharanipragada
  • ACYLATED INDANYL AMINES AND THEIR USE AS PHARMACEUTICALS
    Publication number: 20100183712
    Abstract: The present invention relates to acylated indanyl amines according to the general formula (I) wherein R1-R4 have the meanings given in the description, A is CH2, CHOH or CH—(C1-C3-alkyl), B is CH2 or CH—(C1-C3-alkyl), and R5 is an aryl or heteroaryl group, possibly substituted by the substituents listed in the description.
    Type: Application
    Filed: March 29, 2010
    Publication date: July 22, 2010
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Hartmut STROBEL, Paulus WOHLFART, Alena SAFAROVA, Armin WALSER, Teri SUZUKI, Karl SCHÖNAFINGER, Ramalinga M. DHARANIPRAGADA
  • Acylated indanyl amines and their use as pharmaceuticals
    Patent number: 7713963
    Abstract: The present invention relates to acylated indanyl amines according to the general formula (I) wherein R1—R4 have the meanings given in the description, A is CH2, CHOH or CH—(C1-C3-alkyl), B is CH2 or CH—(C1-C3-alkyl), and R5 is an aryl or heteroaryl group, possibly substituted by the substituents listed in the description.
    Type: Grant
    Filed: October 11, 2006
    Date of Patent: May 11, 2010
    Assignee: sanofi-aventis Deutschland GmbH
    Inventors: Hartmut Strobel, Paulus Wohlfart, Alena Safarova, Armin Walser, Teri Suzuki, Karl Schoenafinger, Ramalinga M. Dharanipragada
  • ACYLATED INDANYL AMINES AND THEIR USE AS PHARMACEUTICALS
    Publication number: 20070082897
    Abstract: The present invention relates to acylated indanyl amines according to the general formula (I) wherein R1—R4 have the meanings given in the description, A is CH2, CHOH or CH—(C1-C3-alkyl), B is CH2 or CH—(C1-C3-alkyl), and R5 is an aryl or heteroaryl group, possibly substituted by the substituents listed in the description.
    Type: Application
    Filed: October 11, 2006
    Publication date: April 12, 2007
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Hartmut STROBEL, Paulus WOHLFART, Alena SAFAROVA, Armin WALSER, Teri SUZUKI, Karl SCHONAFINGER, Ramalinga DHARANIPRAGADA
  • 4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
    Patent number: 7202278
    Abstract: A method of stimulating the expression of endothelial NO-synthase in a mammal, which method comprises administering a physiologically active amount of 4-fluoro-N-indan- 2-yl benzamide according to the formula (I) to the said mammal.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: April 10, 2007
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Paulus Wohlfart, Teri Suzuki, Ramalinga M. Dharanipragada, Alena Safarova, Armin Walser, Hartmut Strobel
  • Acylated indanyl amines and their use as pharmaceuticals
    Patent number: 7179839
    Abstract: The present invention relates to acylated indanyl amines according to the general formula (I) wherein R1–R4 have the meanings given in the description, A is CH2, CHOH or CH—(C1–C3-alkyl), B is CH2 or CH—(C1–C3-alkyl), and R5 is an aryl or heteroaryl group, possibly substituted by the substituents listed in the description.
    Type: Grant
    Filed: February 13, 2002
    Date of Patent: February 20, 2007
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Hartmut Strobel, Paulus Wohlfart, Alena Safarova, Armin Walser, Teri Suzuki, Karl Schönafinger
  • 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
    Publication number: 20050054729
    Abstract: The present invention relates to the method of stimulating the expression of endothelial NO-synthase in a mammal, which method comprises administering a physiologically active amount of 4-fluoro-N-indan-2-yl benzamide according to the formula (I) to the said mammal.
    Type: Application
    Filed: August 18, 2004
    Publication date: March 10, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Paulus Wohlfart, Teri Suzuki, Ramalinga Dharanipragada, Alena Safarova, Armin Walser, Hartmut Strobel
  • 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
    Patent number: 6812253
    Abstract: The present invention relates to the method of stimulating the expression of endothelial NO-synthase in a mammal, which method comprises administering a physiologically active amount of 4-fluoro-N-indan-2-yl benzamide according to the formula (I) to the said mammal.
    Type: Grant
    Filed: July 22, 2003
    Date of Patent: November 2, 2004
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Paulus Wohlfart, Teri Suzuki, Ramalinga M. Dharanipragada, Alena Safarova, Armin Walser, Hartmut Strobel
  • 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
    Publication number: 20040019114
    Abstract: The present invention relates to the method of stimulating the expression of endothelial NO-synthase in a mammal, which method comprises administering a physiologically active amount of 4-fluoro-N-indan-2-yl benzamide according to the formula (I) 1
    Type: Application
    Filed: July 22, 2003
    Publication date: January 29, 2004
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Paulus Wohlfart, Teri Suzuki, Ramalinga M. Dharanipragada, Alena Safarova, Armin Walser, Hartmut Strobel
  • 4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
    Patent number: 6617359
    Abstract: The present invention relates to the method of stimulating the expression of endothelial NO-synthase in a mammal, which method comprises administering a physiologically active amount of 4-fluoro-N-indan-2-yl benzamide according to the formula (I) to the said mammal.
    Type: Grant
    Filed: February 13, 2002
    Date of Patent: September 9, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Paulus Wohlfart, Teri Suzuki, Ramalinga M. Dharanipragada, Alena Safarova, Armin Walser, Hartmut Strobel
  • Acylated indanyl amines and their use as pharmaceuticals
    Publication number: 20030055093
    Abstract: The present invention relates to acylated indanyl amines according to the general formula (I) 1
    Type: Application
    Filed: February 13, 2002
    Publication date: March 20, 2003
    Inventors: Hartmut Strobel, Paulus Wohlfart, Alena Safarova, Armin Walser, Teri Suzuki, Karl Schonafinger, Ramalinga M. Dharanipragada
  • 4-Fluoro-N- indan-2-yl benzamide and its use as a pharmaceutical
    Publication number: 20030022939
    Abstract: The present invention relates to the method of stimulating the expression of endothelial NO-synthase in a mammal, which method comprises administering a physiologically active amount of 4-fluoro-N-indan-2-yl benzamide according to the formula (I) 1
    Type: Application
    Filed: February 13, 2002
    Publication date: January 30, 2003
    Inventors: Paulus Wohlfart, Teri Suzuki, Ramalinga M. Dharanipragada, Alena Safarova, Armin Walser, Hartmut Strobel